The Bottom Line: Jun 30, 2003

Jun 30, 2003

Premium

File Attachments

BottomLine063003.gif

Filed under

Informatics

Breaking News

Analysis of Ancient Plaque Points to Agriculture-Related Oral Microbiome Changes in Southern Europe
Gene-Disrupting Ultra-Rare Variants More Common in Children With Autism Spectrum Disorder
CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance
Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business
Top Five Articles on GenomeWeb Last Week: Pacific Biosciences, Illumina, Natera, and More
Canine Genetics Firm Embark Veterinary Raises $75M in Series B Round

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.

The Bottom Line: Jun 30, 2003

Filed under

Analysis of Ancient Plaque Points to Agriculture-Related Oral Microbiome Changes in Southern Europe

Gene-Disrupting Ultra-Rare Variants More Common in Children With Autism Spectrum Disorder

CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

Top Five Articles on GenomeWeb Last Week: Pacific Biosciences, Illumina, Natera, and More

Canine Genetics Firm Embark Veterinary Raises $75M in Series B Round

Purnell Choppin Dies

Effectiveness May Decline, Data From Israel Suggests

To See Future Risk

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships

Deep-Learning Method Helps Predict Sequencing Depth From DNA Probes
Premium

Sequencing-Based Assessment of CYP2D6 Could Improve Prediction of Drug Response
Premium

Congenica Receives CE Mark for Clinical Decision Support Software

C2i Genomics Teams With Premier for AI-Driven Minimal Residual Disease Detection

The Bottom Line: Jun 30, 2003

Filed under

Deep-Learning Method Helps Predict Sequencing Depth From DNA Probes Premium

Sequencing-Based Assessment of CYP2D6 Could Improve Prediction of Drug Response Premium

Deep-Learning Method Helps Predict Sequencing Depth From DNA Probes
Premium

Sequencing-Based Assessment of CYP2D6 Could Improve Prediction of Drug Response
Premium